483
Jatin Vadhvana, M.B.B.S.Jatin Vadhvana, M.B.B.S. – FDA 483, Mar 31, 2023
Record Details
An FDA inspection of Jatin Vadhvana, M.B.B.S. in Ahmedabad, Gujarat, India, a clinical investigator, revealed deficiencies in informed consent procedures. The firm failed to ensure prospective subjects had sufficient opportunity to consider participation and minimized coercion or undue influence. Specifically, illiterate subjects were enrolled using compensated impartial witnesses who routinely provided this service.
View Company Profile
ID · f6087651-a41a-4021-a0f3-5fb535da72d3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.